Assertio Holdings Inc. Reports Q1 2025 Net Product Sales of $26 Million; Adjusted EBITDA Falls to $0.2 Million from $7.4 Million Previous Year

Reuters
05-13
Assertio Holdings Inc. Reports Q1 2025 Net Product Sales of $26 Million; Adjusted EBITDA Falls to $0.2 Million from $7.4 Million Previous Year

Assertio Holdings Inc. announced its financial results for the first quarter of 2025, reporting total net product sales of $26.0 million, aligning with the company's 2025 outlook. This represents a decrease from the $31.9 million recorded in the same quarter of the previous year. The company reported a net loss of $13.5 million, compared to a net loss of $4.5 million in the prior year quarter. Adjusted EBITDA was significantly lower at $0.2 million, down from $7.4 million in the first quarter of the previous year. This decrease was primarily attributed to lower net product sales and increased cost of sales due to higher Rolvedon volumes. Rolvedon net product sales were $13.1 million, a decline from $14.5 million in the previous year, driven by lower pricing despite higher volume. As part of its long-term business strategy, Assertio aims to create sustainable near-term growth and increased long-term value, focusing on its commercial assets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Assertio Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001808665-25-000011), on May 12, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10